Explained herein are pharmaceutical packaging programs which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate medicine, these kinds of methods including a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen